RAP
Click for more information
0.00% 20.5¢ resapp health limited

Management quickly explained why the 1st US clinical trial...

  1. AlCp
    26,812 Posts.
    lightbulb Created with Sketch. 1737
    clock Created with Sketch.
    21/01/20
    22:16
    Post #: 42502129
    Management quickly explained why the 1st US clinical trial stuffed up and the substantial share holder didn't sell, this issue was quickly resolved and the 2nd US clinical trial was a success, it's not our fault that the market didn't know how to interpret the result so it was sold down back to 7c on low volumes. The pps will recovered to back to where it should have been after the 2nd US clinical trial, mid 30s to low 40s.....Sanofi who has a MC that is 4x bigger than Philips is interested in ResAppDx.....
    RAP Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 30  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.